Bordetella holmesii prosthetic valve endocarditis: A case report and review

Infectious Diseases in Clinical Practice

Volumn 20, Issue 4, 2012, Pages 248-253

  Bush, Larry M ^a,b   Davidson, Erin ^b   Daugherty, Johanna ^b  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bordetella holmesii; prosthetic valve endocarditis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERTAPENEM; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MEROPENEM; PENICILLIN DERIVATIVE; PENICILLIN V; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULTAMICILLIN; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTIFICIAL HEART PACEMAKER; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BIOPROSTHESIS; BORDETELLA; BORDETELLA HOLMESII; CASE REPORT; CLINICAL FEATURE; DEVICE REMOVAL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEVER; GERIATRIC PATIENT; HEART MURMUR; HEART VALVE PROSTHESIS; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; NIGHT SWEAT; NONHUMAN; PROSTHESIS INFECTION; REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84863839310     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/IPC.0b013e318248f14f     Document Type: Review

References (22)

1. Habib G, Thuny F, Avierinos JF. Prosthetic valve endocardidits: current approach and therapeutic options. Prog Cardiovas Dis. 2008;50:274-281.
2. Berbari EF, Cockeerill FR, Steckelbeerg JM. Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc. 1997;72:532-542.
3. Shepard CW, Daneshvar MI, Kaiser RM, et al. Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clin Infect Dis. 2004;38:799-804.
4. Weyant RS, Hollis DG, Weaver RE, et al. Bordetella holmesii sp. Nov., a new gram-negative species associated with septicemia. J Clin Microbiol. 1995;33:1-7.
5. CDC. Updated recommendations for the use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the advisory committee on immunization practices, 2010. MMWR Morb Mort Wkly Rep. 2011;60(1):13-15.
6. Spilker T, Liwienski AA, LiPumma JJ. Identification of Bordetella spp, in respiratory specimens from individuals with cystic fibrosis. Clin Microbiol Infect. 2008;14:504-506.
7. Panagopoulos MI, Saint Jean M, Brun D, et al. Bordetella holmesii bacteremia in asplenic children: report of four cases initially misidentified as Acinetobacter lwoffii. J Clin Microbiol. 2010;48:3762-3764.
8. Ko KS, Peck KR, Oh WS, et al. New species of Bordetella, Bordetella ansorpii sp. Nov., isolated from the purulent exudate of an epidermal cyst. J Clin Microbiol. 2005;43:2516-2519.
9. Yih WK, Silva EA, Ida J, et al. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis. 1999;5:441-443.
10. Lindquist SW,Weber DJ, Mangum ME, et al. Bordetella holmesii sepsis in an asplenic adolescent. Pediatr Infect Dis J. 1995;14:813-815.
11. Morris JT, Myers M. Bacteremia due to Bordetella holmesii. Clin Infect Dis. 1998;27:912-913.
12. Njamkepo E, Delisle F, Hagege I, et al. Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates. Clin Microbiol Infect. 2000;6:131-136.
13. Russell FM, Davis JM, Whippy MJ, et al. Severe Bordetella holmesii infection in a previously healthy adolescent confirmed by gene sequence analysis. Clin Infect Dis. 2001;33:129-130.
14. Greig JR, Gunda SS, Kwan J, et al. Bordetella holmesii bacteremia in an individual on haemodialysis. Scand J Infect Dis. 2001;33:716-717.
15. Dorbecker C, Licht C, Korber F, et al. Community-acquired pneumonia due to Bordetella holmesii in a patient with frequently relapsing nephrotic syndrome. J Infect. 2007;54:e203Ye205.
16. The Johns Hopkins Microbiology Newsletter. October 23, 2007; 26, No. 20.
17. McCavit TL, Grube S, Revell P, et al. Bordetella holmesii bacteremia in sickle cell disease. Pediatr Blood Cancer. 2008;51:814-816.
18. Clare S, Ahmed T, Singh R, et al. Bordetella holmesii: a rare cause of bacterial endocarditis in a post-splenectomy patient. BMJ Case Reports. 2010; doi#: 10.1136/bcr .11.2009.2459.
19. Farley T. 2010 Alert # 23, Bordetella holmesii bacteremia in children. New York City Department of Health and Mental Hygiene, Sept. 8, 2010.
20. Moissenet D, Leverger G, Merens A, et al. Septic arthritis caused by Bordetella holmesii in an adolescent with a chronic hemolytic anaemia. J Med Microbiol. 2011; July 21, 2011 jmm.0.033829-0; published ahead of print July 21, 2011.
21. Preston AJ, Parkhill J, Maskel DJ. The bordetellae: lessons from genomics. Nat Rev Microbiol. 2004;2:379-390.
22. Neo Y, Li R, Howe J, et al. Evidence for an intact polysaccharide capsule in Bordetella pertussis. Microbes Infect. 2010;12: 238-245.